EP2838548

UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Application Number
EP13714128A
Filing Date
Mar 15, 2013
Status
Granted And Under Opposition
Jun 16, 2023
Grant Date
Jul 19, 2023
External Links
Slate, Register

Biblio Summary

The patent EP2838548B1 was granted on Jul 19, 2023 by University Of Washington Through Its Center For Commercialization The patent is currently Granted And Under Opposition.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PAGE, RICHARDApr 16, 2024ADMISSIBLE
JAMES POOLE LIMITEDAug 3, 2023ADMISSIBLE

The table below shows the patents of University Of Washington Through Its Center For Commercialization that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2828218Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus SequencingApr 7, 20213
EP2699593Beta-2 Microglobulin-Deficient CellsNov 4, 20201